Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice

摘要

Schematic description of the experimental design. Cisplatin (2 mg/kg) was administered by intraperitoneal injection for 10 days. On day 12, hESC-MSCs (5 × 106/mouse) were transplanted by tail vein injection. Experimental analyses were performed after 2 and 4 weeks